125 related articles for article (PubMed ID: 1728077)
1. Ranitidine improves postoperative suppression of antibody response to preoperative vaccination.
Nielsen HJ; Hammer JH; Moesgaard F; Heron I; Kehlet H
Surgery; 1992 Jan; 111(1):69-73. PubMed ID: 1728077
[TBL] [Abstract][Full Text] [Related]
2. Immune response to diphtheria booster vaccine in the Baltic states.
Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
[TBL] [Abstract][Full Text] [Related]
3. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
[TBL] [Abstract][Full Text] [Related]
4. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
Vodicková M; Svandová E
Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
[No Abstract] [Full Text] [Related]
5. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
Popescu C; Durbaca S; Ivanov D
Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
Al Aswad IH; Shubair ME
East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia antibody response in healthy volunteers immunized with nonchlamydial antigens: a randomized, double-blind, placebo-controlled study.
Johnsen S; Andersen PL; Stanek G; Christiansen G; Birkelund S; Berthelsen LM; Østergaard L
Clin Infect Dis; 2003 Mar; 36(5):586-91. PubMed ID: 12594639
[TBL] [Abstract][Full Text] [Related]
9. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
Kung FH; Orgel HA; Wallace WW; Hamburger RN
Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
11. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
13. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
Someya S; Mizuhara H; Murata R; Kurokawa M
Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
[TBL] [Abstract][Full Text] [Related]
14. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
15. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
[TBL] [Abstract][Full Text] [Related]
16. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients.
Stevens R; Oliver M; Brogan M; Heiserodt J; Targan S
Gastroenterology; 1985 Jun; 88(6):1860-6. PubMed ID: 3873371
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
Frank JW; Schabas R; Arshinoff R; Brant R
CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis.
Rasmussen LA; Nielsen HJ; Sørensen S; Sørensen C; Rasmussen R; Sørensen S; Moesgaard F; Larsen J
J Am Coll Surg; 1995 Aug; 181(2):138-44. PubMed ID: 7627386
[TBL] [Abstract][Full Text] [Related]
19. The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia.
Van der Velden AM; Van Velzen-Blad H; Claessen AM; Van der Griend R; Oltmans R; Rijkers GT; Biesma DH
Eur J Haematol; 2007 Jul; 79(1):47-52. PubMed ID: 17532765
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.
Sutter RW; Hardy IR; Kozlova IA; Tchoudnaia LM; Gluskevich TG; Marievsky V; Deforest A; Wharton M
J Infect Dis; 2000 Feb; 181 Suppl 1():S197-202. PubMed ID: 10657214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
